BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 31971830)

  • 41. Hydroxyacid Oxidase 2 (HAO2) Inhibits the Tumorigenicity of Hepatocellular Carcinoma and Is Negatively Regulated by miR-615-5p.
    Li Y; Zhang M; Li X; Wang Y; Wang Y; Li Y; Zhu H; Ding H; Li X; Sun S
    J Immunol Res; 2022; 2022():5003930. PubMed ID: 35528616
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RASA1 inhibits the progression of renal cell carcinoma by decreasing the expression of miR-223-3p and promoting the expression of FBXW7.
    Zhang RL; Aimudula A; Dai JH; Bao YX
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32588875
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long intergenic non-coding RNA 1939 eliminates proliferation and migration of human renal cell carcinoma (RCC) cells by down-regulation of miR-154.
    Zhang R; Zhang W; Xu B; Lv C; Hou J; Zhang G
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):695-702. PubMed ID: 32138544
    [TBL] [Abstract][Full Text] [Related]  

  • 44. miR-27a promotes cell proliferation and metastasis in renal cell carcinoma.
    Peng H; Wang X; Zhang P; Sun T; Ren X; Xia Z
    Int J Clin Exp Pathol; 2015; 8(2):2259-66. PubMed ID: 25973137
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC.
    Quan J; Pan X; Li Y; Hu Y; Tao L; Li Z; Zhao L; Wang J; Li H; Lai Y; Zhou L; Lin C; Gui Y; Ye J; Zhang F; Lai Y
    Biomed Pharmacother; 2019 Feb; 110():656-666. PubMed ID: 30551118
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Three LHPP gene-targeting co-expressed microRNAs (microRNA-765, microRNA-21, and microRNA-144) promote proliferation, epithelial-mesenchymal transition, invasion, and are independent prognostic biomarkers in renal cell carcinomas patients.
    Meng K; Li Z; Cui X
    J Clin Lab Anal; 2021 Dec; 35(12):e24077. PubMed ID: 34699621
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Decreased miR-200a-3p is a key regulator of renal carcinoma growth and migration by directly targeting CBL.
    Ding M; Sun X; Zhong J; Zhang C; Tian Y; Ge J; Zhang CY; Zen K; Wang JJ; Zhang C; Wang C
    J Cell Biochem; 2018 Dec; 119(12):9974-9985. PubMed ID: 30171729
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The miR-200 family as prognostic markers in clear cell renal cell carcinoma.
    Saleeb R; Kim SS; Ding Q; Scorilas A; Lin S; Khella HW; Boulos C; Ibrahim G; Yousef GM
    Urol Oncol; 2019 Dec; 37(12):955-963. PubMed ID: 31635993
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA-21 functions as an oncogene and promotes cell proliferation and invasion via TIMP3 in renal cancer.
    Chen J; Gu Y; Shen W
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4566-4576. PubMed ID: 29131259
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of SIRT1/AMPK signaling in the proliferation, migration and invasion of renal cell carcinoma cells.
    Wang X; Lu Y; Tuo Z; Zhou H; Zhang Y; Cao Z; Peng L; Yu D; Bi L
    Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907836
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long noncoding RNA ZFPM2-AS1 regulates renal cell carcinoma progression via miR-130a-3p/ESCO2.
    Zhang G; Liu SL; Yi WT; Dong YP; Wan YX
    Kaohsiung J Med Sci; 2022 Jun; 38(6):530-541. PubMed ID: 35258173
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Restoring the epigenetically silenced PCK2 suppresses renal cell carcinoma progression and increases sensitivity to sunitinib by promoting endoplasmic reticulum stress.
    Xiong Z; Yuan C; Shi J; Xiong W; Huang Y; Xiao W; Yang H; Chen K; Zhang X
    Theranostics; 2020; 10(25):11444-11461. PubMed ID: 33052225
    [No Abstract]   [Full Text] [Related]  

  • 53. MicroRNA-100 Enhances Autophagy and Suppresses Migration and Invasion of Renal Cell Carcinoma Cells via Disruption of NOX4-Dependent mTOR Pathway.
    Liu X; Zhong L; Li P; Zhao P
    Clin Transl Sci; 2022 Feb; 15(2):567-575. PubMed ID: 32356935
    [TBL] [Abstract][Full Text] [Related]  

  • 54. miR‑539 suppresses proliferation and induces apoptosis in renal cell carcinoma by targeting high mobility group A2.
    Ye ZH; Gui DW
    Mol Med Rep; 2018 Apr; 17(4):5611-5618. PubMed ID: 29436648
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long noncoding RNA ZFPM2-AS1 promotes the tumorigenesis of renal cell cancer via targeting miR-137.
    Liu JG; Wang HB; Wan G; Yang MZ; Jiang XJ; Yang JY
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5675-5681. PubMed ID: 31298319
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dual Strands of Pre-miR-149 Inhibit Cancer Cell Migration and Invasion through Targeting FOXM1 in Renal Cell Carcinoma.
    Okato A; Arai T; Yamada Y; Sugawara S; Koshizuka K; Fujimura L; Kurozumi A; Kato M; Kojima S; Naya Y; Ichikawa T; Seki N
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902136
    [TBL] [Abstract][Full Text] [Related]  

  • 57. miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes.
    Chen X; Ruan A; Wang X; Han W; Wang R; Lou N; Ruan H; Qiu B; Yang H; Zhang X
    J Cancer Res Clin Oncol; 2014 Aug; 140(8):1295-304. PubMed ID: 24802708
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-20b-5p functions as a tumor suppressor in renal cell carcinoma by regulating cellular proliferation, migration and apoptosis.
    Li Y; Chen D; Jin L; Liu J; Su Z; Li Y; Gui Y; Lai Y
    Mol Med Rep; 2016 Feb; 13(2):1895-901. PubMed ID: 26708577
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long noncoding RNA HOTAIR promotes renal cell carcinoma malignancy through alpha-2, 8-sialyltransferase 4 by sponging microRNA-124.
    Pan Y; Wu Y; Hu J; Shan Y; Ma J; Ma H; Qi X; Jia L
    Cell Prolif; 2018 Dec; 51(6):e12507. PubMed ID: 30105850
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MiR-212-5p inhibits the malignant behavior of clear cell renal cell carcinoma cells by targeting TBX15.
    Deng JH; Zheng GY; Li HZ; Ji ZG
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10699-10707. PubMed ID: 31858538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.